Baseline expression of exosomal miR-92a-3p and miR-221-3p could predict the response to first-line chemotherapy and survival in metastatic colorectal cancer
The status of predictive biomarkers in metastatic colorectal cancer is currently
underdeveloped. Our study aimed to investigate the predictive value of six circulating …
underdeveloped. Our study aimed to investigate the predictive value of six circulating …
Tumor stem cell-derived exosomal microRNA-17-5p inhibits anti-tumor immunity in colorectal cancer via targeting SPOP and overexpressing PD-L1
W Sun, J Cui, Y Ge, J Wang, Y Yu, B Han, B Liu - Cell Death Discovery, 2022 - nature.com
Exosomes are known to transmit microRNAs (miRNAs) to affect human cancer progression,
and miR-17-5p has been manifested to exert facilitated effects on colorectal cancer (CRC) …
and miR-17-5p has been manifested to exert facilitated effects on colorectal cancer (CRC) …
Serum small RNAs in metastatic colorectal cancer predict response to chemotherapy and characterize high-risk patients
R Mjelle, AK Kristensen, TS Solheim, GS Westvik… - Molecular Cancer, 2024 - Springer
Metastatic colorectal cancer (mCRC) presents significant challenges in clinical management
due to its heterogeneity and variable response to treatment. In this study, we conducted …
due to its heterogeneity and variable response to treatment. In this study, we conducted …
Long non‐coding RNA TMPO‐AS1 facilitates the progression of colorectal cancer cells via sponging miR‐98‐5p to upregulate BCAT1 expression
J Ye, Y Yan, L Xin, J Liu, T Tang… - … of Gastroenterology and …, 2022 - Wiley Online Library
Abstract Background and Aim Colorectal cancer, as a common malignant carcinoma in the
gastrointestinal tract, has a high mortality globally. However, the specific molecular …
gastrointestinal tract, has a high mortality globally. However, the specific molecular …
miR-485-3p and miR-4728-5p as tumor suppressors in pathogenesis of colorectal cancer
T Gurer, A Aytekin, E Caki, S Gezici - Molecular Biology, 2022 - Springer
MicroRNAs (miRNAs) are a class of small noncoding RNAs that have major functions in the
development and progression of colorectal cancer (CRC) as tumor suppressors or …
development and progression of colorectal cancer (CRC) as tumor suppressors or …
Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients
P Jeyananthan - Pathology-Research and Practice, 2023 - Elsevier
SARS-CoV-2 pandemic is the current threat of the world with enormous number of
deceases. As most of the countries have constraints on resources, particularly for intensive …
deceases. As most of the countries have constraints on resources, particularly for intensive …
A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer
Although microRNAs (miRNAs) contribute to all hallmarks of cancer, miRNA dysregulation in
metastasis remains poorly understood. The aim of this work was to reliably identify miRNAs …
metastasis remains poorly understood. The aim of this work was to reliably identify miRNAs …
[Retracted] Ferulic Acid Protects Endothelial Cells from Hypoxia‐Induced Injury by Regulating MicroRNA‐92a
Y Huang, L Tian, Y Liu, J Liu… - Applied Bionics and …, 2022 - Wiley Online Library
Background & Aim. Ferulic acid (FA), the main effective ingredient in Angelica sinensis, has
been widely recognized as the cause of angiogenesis and proliferation of human umbilical …
been widely recognized as the cause of angiogenesis and proliferation of human umbilical …
An independent validation study of candidate microRNAs as predictive biomarkers for bevacizumab-based therapy in patients with metastatic colorectal cancer
D Kiss, T Machackova, K Souckova, P Fabian… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: The monoclonal antibody bevacizumab is a standard drug used in
combination with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) based chemotherapy in the …
combination with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) based chemotherapy in the …
[PDF][PDF] Identifying Candidate Biomarkers of Clinical Response to Ustekinumab in Psoriasis
S Solanky - 2024 - kclpure.kcl.ac.uk
The development and use of biologic drugs, including ustekinumab, secukinumab,
adalimumab and newer anti-interleukin (IL)-23p19 biologics, have revolutionised treatment …
adalimumab and newer anti-interleukin (IL)-23p19 biologics, have revolutionised treatment …